Cost-effectiveness of quetiapine with lithium or divalproex for maintenance treatment of bipolar I disorder

References

• Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF 36. J Health Econ 2002;21:271–292.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Akiskal HS, Angst J, Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543–552.
   PubMed Web of Science ®Google Scholar
• Kleinman L, Lowin A, Flood E, Costs of bipolar disorder. Pharmacoeconomics 2003;21:601–622.
   PubMed Web of Science ®Google Scholar
• Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord 1994;31:91–96.
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry 2008;20:131–137.
   PubMed Web of Science ®Google Scholar
• Ghaemi SN, Boiman EE, Goodwin FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804–808; quiz 809.
   Google Scholar
• Wyatt RJ, Henter I. An economic evaluation of manic-depressive illness – 1991. Soc Psychiatry Psychiatr Epidemiol 1995;30:213–219.
   PubMed Web of Science ®Google Scholar
• Begley CE, Annegers JF, Swann AC, The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001;19:483–495.
   PubMed Web of Science ®Google Scholar
• Knoth RL, Chen K, Tafesse E. Datapoints: costs associated with the treatment of patients with bipolar disorder in a managed care organization. Psychiatr Serv 2004;55:1353.
   PubMed Web of Science ®Google Scholar
• Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(4 Suppl):1–50.
   Web of Science ®Google Scholar
• McIntyre RS, Woldeyohannes HO, Yasgur BS, Maintenance treatment in bipolar disorder: a focus on aripiprazole. Expert Rev Neurother 2007;7:919–925.
   PubMedGoogle Scholar
• Astrazeneca. Seroquel – Prescribing Information, 2007.
   Google Scholar
• Vieta E, Suppes T, Eggens I, Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126). J Affect Disord 2008;109:251–263.
   PubMed Web of Science ®Google Scholar
• Suppes T, Liu S, Brecher M, Paulsson B, on behalf of the Trial 127 Investigators. Maintenance treatment in bipolar I disorder with quetiapine with lithium or divalproex: a placebo-controlled, randomized multicenter trial (trial D1447C00127). Bipolar Disord 2008;10(Suppl 1):40.
   Google Scholar
• Lipscomb J, Weinstein M, Torrance GW. Time preference. In: Gold MR, Siegel J, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press, 1996;214–246.
   Google Scholar
• Simon GE, Hunkeler E, Fireman B, Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord 2007;9:526–530.
   PubMed Web of Science ®Google Scholar
• NCHS. National Vital Statistics Report. Deaths: Final Data for 2004.
   Google Scholar
• Fleurence RL, Hollenbeak CS. Rates and probabilities in economic modelling: transformation, translation and appropriate application. Pharmacoeconomics 2007;25:3–6.
   PubMed Web of Science ®Google Scholar
• Calabrese JR, Bowden CL, Sachs G, A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64:1013–1024.
   PubMed Web of Science ®Google Scholar
• Calvert NW, Burch SP, Fu AZ, The cost-effectiveness of lamotrigine in the maintenance treatment of adults with bipolar I disorder. J Manag Care Pharm 2006;12:322–330.
   PubMed Web of Science ®Google Scholar
• Bowden CL, Calabrese JR, Sachs G, A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392–400.
   PubMed Web of Science ®Google Scholar
• Thomson P. Red Book [TM] for Windows (2007) Vol 43.
   Google Scholar
• US Department of Labor BoLS. Consumer price indexes: US Depart. of Labor, Bureau of Labor Statistics [on-line]. Available at: http://www.bls.gov/cpi/ [Last accessed 10 Oct 2007].
   Google Scholar
• Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations CMAJ 1992;146:473–481.
   Google Scholar
• Briggs A, Gray A. Using cost-effectiveness information. BMJ 2000;320:246.
   PubMed Web of Science ®Google Scholar
• Soares-Weiser K, Bravo Vergel Y, Beynon S, A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder. Health Technol Assess 2007;11: iii–iv, ix–206.
   PubMed Web of Science ®Google Scholar
• Fleurence RL, Chatterton ML, Dixon JM, Rajagopalan K. Economic outcomes associated with atypical antipsychotics in bipolar disorder: a systematic review. Prim Care Companion J Clin Psychiatry 2007;9:419–428.
   PubMedGoogle Scholar
• Kessing LV, Munk-Jorgensen P. Does type of first contact in depressive and bipolar disorders predict subsequent hospitalisation and risk of suicide? J Affect Disord 2004;83:65–71.
   PubMed Web of Science ®Google Scholar
• DeFrances CJ, Cullen KA, Kozak LJ. National hospital discharge survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13, 2007 :Table 13.
   Google Scholar
• Revicki DA, Matza LS, Flood E, Lloyd A. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005;23:583–594.
   PubMed Web of Science ®Google Scholar
• Revicki DA, Wood M. Patient-assigned health state utilities for depression-related outcomes: differences by depression severity and antidepressant medications. J Affect Disord 1998;48:25–36.
   PubMed Web of Science ®Google Scholar
• McKendrick J, Cerri KH, Lloyd A, Cost-effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom. J Psychopharmacol 2007;21:588–596
   PubMed Web of Science ®Google Scholar